UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 257

Sortiert nach

C.04.01 Protecting patients from the long-term consequences of schizophrenia

European neuropsychopharmacology, 2013-10, Vol.23, p.S632-S633

Kane, J.M

2013

Volltextzugriff (PDF)

Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy

European journal of surgical oncology, 2009-04, Vol.35 (4), p.356-361

2009

Volltextzugriff (PDF)

C.07.04 Is there a sense of urgency to optimise relapse prevention and functioning in patients with schizophrenia?

European neuropsychopharmacology, 2019-12, Vol.29, p.S594-S595

Kane, J.M.

2019

Volltextzugriff (PDF)

C.01.02 Individualisation of treatment in schizophrenia

European neuropsychopharmacology, 2019, Vol.29, p.S616-S616

Kane, J.M.

2019

Volltextzugriff (PDF)

Efficacy of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator

European neuropsychopharmacology, 2016-10, Vol.26, p.S580-S580

2016

Volltextzugriff (PDF)

Safety of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator

European neuropsychopharmacology, 2016-10, Vol.26, p.S580-S581

2016

Volltextzugriff (PDF)

Drought-induced mortality of a foundation species (Juniperus monosperma) promotes positive afterlife effects in understory vegetation

Plant ecology, 2011-05, Vol.212 (5), p.733-741

2011

Volltextzugriff (PDF)

The concept of resilience: definition and measurement

European neuropsychopharmacology, 2017-10, Vol.27, p.S543-S544

Kane, J.M.

2017

Volltextzugriff (PDF)

S.15.01 - The concept of resilience: definition and measurement

European neuropsychopharmacology, 2017-10, Vol.27, p.S543-S544

Kane, J.M.

2017

Volltextzugriff (PDF)

Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing

Experimental and molecular pathology, 2003-06, Vol.74 (3), p.244-255

2003

Volltextzugriff (PDF)

Seed banks in a degraded desert shrubland: Influence of soil surface condition and harvester ant activity on seed abundance

Journal of arid environments, 2009-10, Vol.73 (10), p.885-893

2009

Volltextzugriff (PDF)

P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies

European neuropsychopharmacology, 2015-09, Vol.25, p.S522-S523

2015

Volltextzugriff (PDF)

P.461 Behavioral economics to improve medication adherence in severe mental illness: A systematic review of current evidence

European neuropsychopharmacology, 2019-12, Vol.29, p.S326-S327

2019

Volltextzugriff (PDF)

Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone

Brain, behavior, and immunity, 2017-08, Vol.64, p.320-329

2017

Volltextzugriff (PDF)

P.3.d.046 Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study

European neuropsychopharmacology, 2014-10, Vol.24, p.S549-S550

2014

Volltextzugriff (PDF)

P.3.d.037 Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly

European neuropsychopharmacology, 2014-10, Vol.24, p.S543-S544

2014

Volltextzugriff (PDF)

P.3.d.034 Effects of aripiprazole once-monthly on functioning in patients with schizophrenia

European neuropsychopharmacology, 2014-10, Vol.24, p.S541-S542

2014

Volltextzugriff (PDF)

P.3.c.033 Long-acting injectable vs. oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image and cohort studies

European neuropsychopharmacology, 2012-10, Vol.22, p.S335-S336

2012

Volltextzugriff (PDF)

Inverse relationship between body mass index and mortality in older nursing-home residents: A collaborative meta-analysis of 19,538 elderly subjects

Nutrition (Burbank, Los Angeles County, Calif.), 2016-03, Vol.32 (3), p.399-400

2016

Volltextzugriff (PDF)

Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists

Brain, behavior, and immunity, 2011-06, Vol.25 (Suppl 1), p.S137-S145

2011

Volltextzugriff (PDF)

DYSGLYCEMIC SIGNALS IN CHILDREN AND ADOLESCENTS TREATED WITH ANTIPSYCHOTICS FOR THE FIRST TIME

Schizophrenia research, 2014-04, Vol.153, p.S19-S19

2014

Volltextzugriff (PDF)

P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia

European neuropsychopharmacology, 2012-10, Vol.22, p.S327-S327

2012

Volltextzugriff (PDF)

P.3.d.027 Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazole

European neuropsychopharmacology, 2013-10, Vol.23, p.S473-S474

2013

Volltextzugriff (PDF)

HSD3 Real-World Outcomes and Practice Patterns for Long-Acting Injectable Vs. Oral Antipsychotic Agents Among Hospitalized Patients with Schizophrenia in the United States

Value in health, 2023-06, Vol.26 (6), p.S239-S239

2023

Volltextzugriff (PDF)

Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

Value in health, 2013-11, Vol.16 (7), p.A550-A550

2013

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(242)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C.04.01 Protecting patients from the long-term consequences of schizophrenia

Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy

C.07.04 Is there a sense of urgency to optimise relapse prevention and functioning in patients with schizophrenia?

C.01.02 Individualisation of treatment in schizophrenia

Efficacy of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator

Safety of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator

Drought-induced mortality of a foundation species (Juniperus monosperma) promotes positive afterlife effects in understory vegetation

The concept of resilience: definition and measurement

S.15.01 - The concept of resilience: definition and measurement

Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing

Seed banks in a degraded desert shrubland: Influence of soil surface condition and harvester ant activity on seed abundance

P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies

P.461 Behavioral economics to improve medication adherence in severe mental illness: A systematic review of current evidence

Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone

P.3.d.046 Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study

P.3.d.037 Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly

P.3.d.034 Effects of aripiprazole once-monthly on functioning in patients with schizophrenia

P.3.c.033 Long-acting injectable vs. oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image and cohort studies

Inverse relationship between body mass index and mortality in older nursing-home residents: A collaborative meta-analysis of 19,538 elderly subjects

Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists

DYSGLYCEMIC SIGNALS IN CHILDREN AND ADOLESCENTS TREATED WITH ANTIPSYCHOTICS FOR THE FIRST TIME

P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia

P.3.d.027 Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazole

HSD3 Real-World Outcomes and Practice Patterns for Long-Acting Injectable Vs. Oral Antipsychotic Agents Among Hospitalized Patients with Schizophrenia in the United States

Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

Suchergebnisse filtern